322
Views
0
CrossRef citations to date
0
Altmetric
Case Reports

A mild clinical and neuropsychological phenotype of Renpenning syndrome: A new case report with a maternally inherited PQBP1 missense mutation

, , , , , , , , , , & show all

References

  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders: DSM-5 (5th ed.). American Psychiatric Association.
  • Andreu Barrachina, L., & Sanz-Torrent, M. (2013). Evaluación e identificación del los niños con TEL. In L. Andreu Barrachina & G. Aguado Alonso (Eds.), El trastorno específico del lenguaje: diagnóstico e intervención (pp. 89–136.). UOC.
  • Bourgeron, T. (2016). The genetics and neurobiology of ESSENCE: The third Birgit Olsson lecture. Nordic Journal of Psychiatry, 70(1), 1–9. https://doi.org/10.3109/08039488.2015.1042519
  • Conners, C. K. (2004). Conners’ continuous performance test (CPT II): Version 5 for Windows: technical guide and software manual. MHS.
  • DuPaul, G. J. (1998). ADHD rating scale-IV: Checklists, norms, and clinical interpretation. Guilford Press.
  • Fernandez-Jaen, A., Cigudosa, J. C., Martin Fernandez-Mayoralas, D., Suela, J., Fernandez-Perrone, A. L., Calleja-Perez, B., & Lopez-Martin, S. (2014). Genetics applied to clinical practice in neurodevelopmental disorders. Rev Neurol, 58 (Suppl 1), S65–S70. http://www.ncbi.nlm.nih.gov/pubmed/25252670
  • Flanagan, D. P., & Kaufman, A. S. (2009). Essentials of WISC-IV assessment (2nd ed.). John Wiley and Sons.
  • Flynn, M., Zou, Y. S., & Milunsky, A. (2011). Whole gene duplication of the PQBP1 gene in syndrome resembling Renpenning. American Journal of Medical Genetics. Part A, 155A(1), 141–144. https://doi.org/10.1002/ajmg.a.33756
  • Frazier, T. W., Demaree, H. A., & Youngstrom, E. A. (2004). Meta-analysis of intellectual and neuropsychological test performance in attention-deficit/hyperactivity disorder. Neuropsychology, 18(3), 543–555. https://doi.org/10.1037/0894-4105.18.3.543
  • Germanaud, D., Rossi, M., Bussy, G., Gérard, D., Hertz-Pannier, L., Blanchet, P., Dollfus, H., Giuliano, F., Bennouna-Greene, V., Sarda, P., Sigaudy, S., Curie, A., Vincent, M. C., Touraine, R., & Des Portes, V. (2011). The Renpenning syndrome spectrum: New clinical insights supported by 13 new PQBP1-mutated males. Clinical Genetics, 79(3), 225–235. https://doi.org/10.1111/j.1399-0004.2010.01551.x
  • Hawi, Z., Cummins, T. D., Tong, J., Johnson, B., Lau, R., Samarrai, W., & Bellgrove, M. A. (2015). The molecular genetic architecture of attention deficit hyperactivity disorder. Molecular Psychiatry, 20(3), 289–297. https://doi.org/10.1038/mp.2014.183
  • Iwamoto, K., Huang, Y., & Ueda, S. (2000). Genomic organization and alternative transcripts of the human PQBP-1 gene. Gene, 259(1-2), 69–73. https://doi.org/10.1016/S0378-1119(00)00437-6
  • Iwasaki, Y., & Thomsen, G. H. (2014). The splicing factor PQBP1 regulates mesodermal and neural development through FGF signaling. Development (Cambridge, England), 141(19), 3740–3751. https://doi.org/10.1242/dev.106658
  • Kalscheuer, V. M., Freude, K., Musante, L., Jensen, L. R., Yntema, H. G., Gécz, J., Sefiani, A., Hoffmann, K., Moser, B., Haas, S., Gurok, U., Haesler, S., Aranda, B., Nshedjan, A., Tzschach, A., Hartmann, N., Roloff, T.-C., Shoichet, S., Hagens, O., … Ropers, H.-H. (2003). Mutations in the polyglutamine binding protein 1 gene cause X-linked mental retardation. Nature Genetics, 35(4), 313–315. https://doi.org/10.1038/ng1264
  • Kirk, S. A., McCarthy, J. J., & Kirk, W. D. (1976). Examiner’s manual: Illinois test of Psycholinguistic abilities (9th ed.). University of Illinois.
  • Kleefstra, T., Franken, C. E., Arens, Y. H. J. M., Ramakers, G. J. A., Yntema, H. G., Sistermans, E. A., Hulsmans, C. F. C. H., Nillesen, W. N., van Bokhoven, H., de Vries, B. B. A., & Hamel, B. C. J. (2004). Genotype-phenotype studies in three families with mutations in the polyglutamine-binding protein 1 gene (PQBP1). Clinical Genetics, 66(4), 318–326. https://doi.org/10.1111/j.1399-0004.2004.00308.x
  • Koenig, R., Meinecke, P., Kuechler, A., Schafer, D., & Muller, D. (2010). Wiedemann-Steiner syndrome: three further cases. American Journal of Medical Genetics. Part A, 152A(9), 2372–2375. https://doi.org/10.1002/ajmg.a.33587
  • Koppitz, E. M. (1975). The Bender gestalt test for young children. Volume II, research and application, 1963–1973. Grune & Stratton.
  • Kunde, S. A., Musante, L., Grimme, A., Fischer, U., Muller, E., Wanker, E. E., & Kalscheuer, V. M. (2011). The X-chromosome-linked intellectual disability protein PQBP1 is a component of neuronal RNA granules and regulates the appearance of stress granules. Human Molecular Genetics, 20(24), 4916–4931. https://doi.org/10.1093/hmg/ddr430
  • Lenski, C., Abidi, F., Meindl, A., Gibson, A., Platzer, M., Frank Kooy, R., Lubs, H. A., Stevenson, R. E., Ramser, J., & Schwartz, C. E. (2004). Novel truncating mutations in the polyglutamine tract binding protein 1 gene (PQBP1) cause Renpenning syndrome and X-linked mental retardation in another family with microcephaly. American Journal of Human Genetics, 74(4), 777–780. https://doi.org/10.1086/383205
  • Lezak, M. D. (1995). Neuropsychological assessment (3rd ed.). Oxford University Press.
  • Lubs, H., Abidi, F. E., Echeverri, R., Holloway, L., Meindl, A., Stevenson, R. E., & Schwartz, C. E. (2006). Golabi-Ito-Hall syndrome results from a missense mutation in the WW domain of the PQBP1 gene. Journal of Medical Genetics, 43(6), e30. https://doi.org/10.1136/jmg.2005.037556
  • Miyake, N., Tsurusaki, Y., Koshimizu, E., Okamoto, N., Kosho, T., Brown, N. J., Tan, T. Y., Yap, P. J. J., Suzumura, H., Tanaka, T., Nagai, T., Nakashima, M., Saitsu, H., Niikawa, N., & Matsumoto, N. (2016). Delineation of clinical features in Wiedemann-Steiner syndrome caused by KMT2A mutations. Clinical Genetics, 89(1), 115–119. https://doi.org/10.1111/cge.12586
  • Mizuguchi, M., Obita, T., Serita, T., Kojima, R., Nabeshima, Y., & Okazawa, H. (2014). Mutations in the PQBP1 gene prevent its interaction with the spliceosomal protein U5-15 kD. Nature Communications, 5, 3822. https://doi.org/10.1038/ncomms4822
  • Oakland, T., & Harrison, P. L. (2008). Adaptive Behavior Assessment System-II clinical use and interpretation (1st ed.). Elsevier/Academic Press.
  • Okazawa, H., Rich, T., Chang, A., Lin, X., Waragai, M., Kajikawa, M., Enokido, Y., Komuro, A., Kato, S., Shibata, M., Hatanaka, H., Mouradian, M. M., Sudol, M., & Kanazawa, I. (2002). Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron, 34(5), 701–713. https://doi.org/10.1016/S0896-6273(02)00697-9
  • Qi, Y., Hoshino, M., Wada, Y-i., Marubuchi, S., Yoshimura, N., Kanazawa, I., Shinomiya, K-i., & Okazawa, H. (2005). PQBP-1 is expressed predominantly in the central nervous system during development. The European Journal of Neuroscience, 22(6), 1277–1286. https://doi.org/10.1111/j.1460-9568.2005.04339.x
  • Redin, C., Gérard, B., Lauer, J., Herenger, Y., Muller, J., Quartier, A., Masurel-Paulet, A., Willems, M., Lesca, G., El-Chehadeh, S., Le Gras, S., Vicaire, S., Philipps, M., Dumas, M., Geoffroy, V., Feger, C., Haumesser, N., Alembik, Y., Barth, M., … Piton, A. (2014). Efficient strategy for the molecular diagnosis of intellectual disability using targeted high-throughput sequencing. Journal of Medical Genetics, 51(11), 724–736. https://doi.org/10.1136/jmedgenet-2014-102554
  • Reitan, R. M. (1971). Trail making test results for normal and brain-damaged children. Perceptual and Motor Skills, 33(2), 575–581. https://doi.org/10.2466/pms.1971.33.2.575
  • Renpenning, H., Gerrard, J. W., Zaleski, W. A., & Tabata, T. (1962). Familial sex-linked mental retardation. Canadian Medical Association Journal, 87, 954–956. https://www.ncbi.nlm.nih.gov/pubmed/13981686
  • Rey, A. (1941). L’examen psychologique dans les cas d’encephalopathie traumatique [The psychological examination of traumatic encephalopathy]. Archives de Psychologie, 28, 286–340.
  • Rey, G. J., & Benton, A. L. (1991). Examen de afasia multilingüe: (Multilingual Aphasia Examination-Spanish). AJA Associates.
  • Shallice, T. (1982). Specific impairments of planning. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 298(1089), 199–209. https://doi.org/10.1098/rstb.1982.0082
  • Stam, A. J., Schothorst, P. F., Vorstman, J. A., & Staal, W. G. (2009). The genetic overlap of attention deficit hyperactivity disorder and autistic spectrum disorder. The Application of Clinical Genetics, 2, 7–13. https://www.ncbi.nlm.nih.gov/pubmed/23776346 https://doi.org/10.2147/tacg.s4683
  • Steiner, C. E., & Marques, A. P. (2000). Growth deficiency, mental retardation and unusual facies. Clinical Dysmorphology, 9(2), 155–156. https://doi.org/10.1097/00019605-200009020-00021
  • Stevenson, R. E., Arena, J. F., Ouzts, E., Gibson, A., Shokeir, M. H., Vnencak-Jones, C., Lubs, H. A., May, M., & Schwartz, C. E. (1998). Renpenning syndrome maps to Xp11. American Journal of Human Genetics, 62(5), 1092–1101. https://doi.org/10.1086/301835
  • Stevenson, R. E., Bennett, C. W., Abidi, F., Kleefstra, T., Porteous, M., Simensen, R. J., Lubs, H. A., Hamel, B. C. J., & Schwartz, C. E. (2005). Renpenning syndrome comes into focus. American Journal of Medical Genetics. Part A, 134(4), 415–421. https://doi.org/10.1002/ajmg.a.30664
  • Strom, S. P., Lozano, R., Lee, H., Dorrani, N., Mann, J., O'Lague, P. F., Mans, N., Deignan, J. L., Vilain, E., Nelson, S. F., Grody, W. W., & Quintero-Rivera, F. (2014). De Novo variants in the KMT2A (MLL) gene causing atypical Wiedemann-Steiner syndrome in two unrelated individuals identified by clinical exome sequencing. BMC Medical Genetics, 15, 49. https://doi.org/10.1186/1471-2350-15-49
  • Takahashi, M., Mizuguchi, M., Shinoda, H., Aizawa, T., Demura, M., Okazawa, H., & Kawano, K. (2010). Polyglutamine tract-binding protein-1 binds to U5-15kD via a continuous 23-residue segment of the C-terminal domain. Biochimica et Biophysica Acta, 1804(7), 1500–1507. https://doi.org/10.1016/j.bbapap.2010.03.007
  • Wan, D., Zhang, Z. C., Zhang, X., Li, Q., & Han, J. (2015). X chromosome-linked intellectual disability protein PQBP1 associates with and regulates the translation of specific mRNAs. Human Molecular Genetics, 24(16), 4599–4614. https://doi.org/10.1093/hmg/ddv191
  • Wang, Q., Moore, M. J., Adelmant, G., Marto, J. A., & Silver, P. A. (2013). PQBP1, a factor linked to intellectual disability, affects alternative splicing associated with neurite outgrowth. Genes & Development, 27(6), 615–626. https://doi.org/10.1101/gad.212308.112
  • Webster, R. I., Erdos, C., Evans, K., Majnemer, A., Kehayia, E., Thordardottir, E., Evans, A., & Shevell, M. I. (2006). The clinical spectrum of developmental language impairment in school-aged children: language, cognitive, and motor findings. Pediatrics, 118(5), e1541–e1549. https://doi.org/10.1542/peds.2005-2761
  • Wechsler, D. (2003). WISC-IV: Weschsler intelligence scale for children (4th ed.). London etc.
  • Wiedemann, H. R., Kunze, J., Grosse, F. R., & Dibbern, H. (1989). A syndrome of abnormal facies, short stature, and psychomotor retardation Atlas of Clinical Syndromes: A Visual Aid to Diagnosis for Clinicians and Practicing Physicians (2nd ed., pp. 198–199). Wolf Publishing Ltd.
  • Zhang, X.-Y., Qi, J., Shen, Y.-Q., Liu, X., Liu, A., Zhou, Z., Han, J., & Zhang, Z. C. (2017). Mutations of PQBP1 in Renpenning syndrome promote ubiquitin-mediated degradation of FMRP and cause synaptic dysfunction. Human Molecular Genetics, 26(5), 955–968. https://doi.org/10.1093/hmg/ddx010

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.